Citation(s)
- Barker JN, Ashton RE, Marks R, Harris RI, Berth-Jones J
Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator. Br J Dermatol. 1999 Aug;141(2):274-8.
- Bourke JF, Berth-Jones J, Iqbal SJ, Hutchinson PE
High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris. Br J Dermatol. 1993 Jul;129(1):74-6.
- Bourke JF, Berth-Jones J, Mumford R, Iqbal SJ, Hutchinson PE
High dose topical calcipotriol consistently reduces serum parathyroid hormone levels. Clin Endocrinol (Oxf). 1994 Sep;41(3):295-7.
- Bourke JF, Iqbal SJ, Hutchinson PE
Vitamin D analogues in psoriasis: effects on systemic calcium homeostasis. Br J Dermatol. 1996 Sep;135(3):347-54. Review.
- Frappaz A, Thivolet J
(1993). Calcipotriol in combination with PUVA: A randomized double-blind placebo study in severe psoriasis. European Journal of Dermatology. 3:351-354.
- Javitz HS, Ward MM, Farber E, Nail L, Vallow SG
The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol. 2002 Jun;46(6):850-60.
- Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001 Mar;137(3):280-4.
- Lamba S, Lebwohl M
Combination therapy with vitamin D analogues. Br J Dermatol. 2001 Apr;144 Suppl 58:27-32. Review.
- Lebwohl M, Ali S
Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol. 2001 Oct;45(4):487-98; quiz 499-502. Review.
- Salmhofer W, Maier H, Soyer HP, Hönigsmann H, Hödl S
Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis. Acta Derm Venereol Suppl (Stockh). 2000;(211):5-8.
A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Study of the Safety and Efficacy of Two Dosing Regimens of QRX-101 (Becocalcidiol) Ointment in the Treatment of Plaque-Type Psoriasis
Details for clinical trial NCT00373516
